Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
7.03
-0.35 (-4.74%)
Nov 13, 2026, 4:00 PM EST - Market closed
Rockwell Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 72.58 | 69.26 | 101.49 | 83.61 | 72.81 | 61.93 | |
Revenue Growth | -3.96% | -31.76% | 21.38% | 14.84% | 17.57% | -0.43% |
Cost of Revenue | 59.46 | 57.56 | 84.01 | 74.91 | 68.73 | 64.35 |
Gross Profit | 13.13 | 11.7 | 17.48 | 8.7 | 4.08 | -2.42 |
Selling, General & Admin | 17.29 | 16.39 | 16.86 | 14.27 | 17.74 | 21.08 |
Research & Development | 0.15 | - | 0.02 | 1.11 | 3.12 | 6.84 |
Operating Expenses | 17.44 | 16.39 | 16.88 | 15.37 | 20.86 | 27.92 |
Operating Income | -4.31 | -4.69 | 0.61 | -6.67 | -16.78 | -30.34 |
Interest Expense | -1.13 | -1.12 | -1.25 | -2.3 | -1.94 | -2.36 |
Interest & Investment Income | 0.17 | 0.23 | 0.09 | 0.21 | 0.03 | 0.02 |
Other Non Operating Income (Expenses) | -0.85 | - | - | - | - | - |
EBT Excluding Unusual Items | -6.12 | -5.58 | -0.55 | -8.76 | -18.68 | -32.67 |
Gain (Loss) on Sale of Investments | 0.46 | 0.27 | 0.07 | 0.32 | 0 | - |
Pretax Income | -5.66 | -5.31 | -0.48 | -8.44 | -18.68 | -32.67 |
Net Income | -5.66 | -5.31 | -0.48 | -8.44 | -18.68 | -32.67 |
Preferred Dividends & Other Adjustments | 0.15 | 0.15 | 0.3 | 0.15 | - | - |
Net Income to Common | -5.81 | -5.47 | -0.78 | -8.59 | -18.68 | -32.67 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 4 | 4 | 3 | 2 | 1 | 1 |
Shares Outstanding (Diluted) | 4 | 4 | 3 | 2 | 1 | 1 |
Shares Change | 15.16% | 15.83% | 33.17% | 63.05% | 67.77% | 24.02% |
EPS (Basic) | -1.47 | -1.52 | -0.25 | -3.68 | -13.06 | -38.32 |
EPS (Diluted) | -1.47 | -1.52 | -0.25 | -3.68 | -13.06 | -38.32 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -1.2 | 3.19 | -9.7 | -17.21 | -34.06 |
Free Cash Flow Per Share | - | -0.33 | 1.03 | -4.16 | -12.03 | -39.94 |
Gross Margin | 18.09% | 16.89% | 17.23% | 10.41% | 5.60% | -3.91% |
Operating Margin | -5.94% | -6.77% | 0.60% | -7.98% | -23.05% | -48.98% |
Profit Margin | -8.00% | -7.89% | -0.77% | -10.27% | -25.65% | -52.76% |
Free Cash Flow Margin | - | -1.73% | 3.14% | -11.60% | -23.64% | -54.99% |
EBITDA | -2.29 | -2.5 | 2.79 | -5.23 | -16.2 | -29.67 |
EBITDA Margin | -3.16% | -3.61% | 2.75% | -6.25% | -22.25% | -47.91% |
D&A For EBITDA | 2.02 | 2.19 | 2.18 | 1.44 | 0.58 | 0.67 |
EBIT | -4.31 | -4.69 | 0.61 | -6.67 | -16.78 | -30.34 |
EBIT Margin | -5.94% | -6.77% | 0.60% | -7.98% | -23.05% | -48.98% |